HuagongsheHuagongshe Chemistry Print Report · For research reference only
Salicylamide → 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Salicylamide | HCID 5147 | — |
| Reactant | Salicyloyl chloride | HCID 74041 | — |
| Reactant | Deferasirox | HCID 214348 | — |
| Product | 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one | HCID 135685723 | — |
Reaction Steps
U.S. Pat. No. 6,465,504 discloses a process for preparing Deferasirox wherein the process includes reacting salicyloyl chloride with salicylamide at 170° C. to obtain 2-(2-hydroxyphenyl)benz[e][1,3]oxazin-4-one, and further crystallization in ethanol to obtain slight yellow color crystals of 2-(2-hydroxyphenyl)benz[e][1,3]oxazin-4-one. 2-(2-hydroxyphenyl)benz[e][1,3]oxazin-4-one which is further reacted with 4-hydrazinebenzoic acid in presence of ethanol to give Deferasirox. Major drawback of this process is preparation of 2-(2-hydroxyphenyl)benz[e][1,3]oxazin-4-one at high temperature and in the absence of solvent which causes formation of several impurities which is difficult to avoid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09018389B2 |
| Source dataset | uspto-grants-2015_04 |
| ORD ID | ord-3511eb47eeac486bb5f425ef0f7aa513 |
| Source note | uspto-grants-2015_04 |